TrueBlue (TBI) Tops Q1 EPS by 5c

TrueBlue (NYSE: TBI) reported Q1 EPS of ($0.06), $0.05 better than the analyst estimate of ($0.11). Revenue for the quarter came in at $465 million versus the consensus estimate of $465.3 million.

For earnings history and earnings-related data on TrueBlue (TBI) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Neumora Therapeutics, Inc. (NMRA) Tops Q2 EPS by 4c
• Rein Therapeutics Inc. (RNTX) Tops Q2 EPS by 39c